Epigenomics AG Stock OTC Markets
Stocks
EPGNF
DE000A37FT41
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.120 USD | +17.89% |
|
-.--% | - |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 1.23M 1.4M 1.13M 1.05M 1.99M 134M 2.03M 13.55M 5.27M 65.73M 5.27M 5.16M 227M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 12.19M 13.95M 11.21M 10.45M 19.81M 1.33B 20.11M 135M 52.3M 653M 52.36M 51.24M 2.25B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +17.89% |
| 1 year | 0.95 |  | 1.12 |
| 3 years | 0.5 | | 1.12 |
| 5 years | 0.24 | | 1.76 |
| 10 years | 0.24 | | 8.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.89% | -.--% | - | - | 1.4M | |
| +0.95% | -.--% | +96.61% | +12.37% | 20.03B | |
| -4.63% | -5.64% | +107.49% | +129.05% | 4.55B | |
| -5.27% | +1.10% | +79.58% | +217.22% | 3.39B | |
| +2.15% | +5.68% | -25.47% | -39.18% | 2.07B | |
| +8.56% | +1.41% | +146.29% | -39.30% | 1.92B | |
| -0.21% | +1.28% | +51.72% | +243.82% | 1.51B | |
| -1.79% | -2.89% | +126.22% | -51.45% | 891M | |
| +2.32% | +6.54% | -34.86% | -16.56% | 498M | |
| -0.83% | +8.52% | -5.51% | - | 473M | |
| Average | +1.91% | +0.84% | +60.23% | +57.00% | 3.93B | |
| Weighted average by Cap. | -0.00% | +0.51% | +87.54% | +49.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.45K 22.06K 20.56K 38.99K 2.61M 39.59K 265K 103K 1.28M 103K 101K 4.43M |
| Net income | -3.35M -3.83M -3.08M -2.87M -5.45M -365M -5.53M -36.98M -14.38M -179M -14.39M -14.08M -618M | -314K -359K -289K -269K -510K -34.2M -518K -3.46M -1.35M -16.81M -1.35M -1.32M -57.93M |
| Net Debt | 10.46M 11.96M 9.61M 8.96M 16.99M 1.14B 17.24M 115M 44.84M 560M 44.89M 43.93M 1.93B | 10.97M 12.55M 10.08M 9.39M 17.82M 1.19B 18.09M 121M 47.04M 587M 47.09M 46.08M 2.02B |
Employees
3
| Date | Price | Change | Volume |
|---|
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
- EPGNF Stock
Select your edition
All financial news and data tailored to specific country editions
